The browser-based ArxLab suite of applications, deployed in hours, will optimize internal and external workflows.
Fort Lee, NJ (April 2, 2013) — Arxspan, the developer of the web-based ArxLab electronic laboratory notebook (ELN), has joined with SAFE-BioPharma Association to provide services that can facilitate research collaboration within the community of biopharmaceutical companies comprising SAFE-BioPharma's members.
"Browser-based digital ELN signatures significantly reduce the barriers to signature compliance for external research initiatives", said Peter Rosati, CEO of Arxspan.
SAFE-BioPharma is the not-for-profit biopharmaceutical industry coalition managing the global SAFE-BioPharma digital identity and signature standard. High assurance digital identity credentials based on the SAFE-BioPharma standard are used in the biopharmaceutical and healthcare sectors to sign electronic documents and data files and to authenticate to online applications.
ArxLab, a full-featured and browser-based ELN built for collaborative research, now incorporates digital signing certificates compliant with the SAFE-BioPharma standard, allowing personnel with SAFE-BioPharma cyber-identities to authenticate identity and apply digital signatures when using the ArxLab ELN.
"We are pleased to welcome Arxspan to the expanding community of SAFE-BioPharma organizations," said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association.
For more information on the SAFE-BioPharma standard for digital identity and digital signatures used in life science and healthcare settings, visit http://www.safe-biopharma.org.
For more information on Arxspan and the ArxLab suite of products for the life science, food science, and chemical industries, visit http://www.arxspan.com.
SAFE-BioPharma® is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE-BioPharma Association.
Arxspan & Arxlab are registered trademarks of Arxspan, LLC.